KAUEROVÁ, Tereza, Peter KOLLÁR and Pavel SUCHÝ. In vitro cytotoxicity evaluation of selected materials for wound dressing application. In 27th Interdisciplinary Toxicology Conference TOXCON 2022. 2022. ISSN 0372-7025.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name In vitro cytotoxicity evaluation of selected materials for wound dressing application
Name in Czech In vitro hodnocení cytotoxicity vybraných krycích materiálu pro hojení ran
Authors KAUEROVÁ, Tereza (203 Czech Republic, belonging to the institution), Peter KOLLÁR (203 Czech Republic, belonging to the institution) and Pavel SUCHÝ (203 Czech Republic, belonging to the institution).
Edition 27th Interdisciplinary Toxicology Conference TOXCON 2022, 2022.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 30108 Toxicology
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
WWW URL
RIV identification code RIV/00216224:14160/22:00134443
Organization unit Faculty of Pharmacy
ISSN 0372-7025
Keywords in English medical devices; wound dressings; cytotoxicity
Tags rivok, ÚFTo
Changed by Changed by: JUDr. Sabina Krejčiříková, učo 383857. Changed: 29/5/2023 13:52.
Abstract
Every medical device that is in contact with human body must be subjected to series of biological tests during the risk assessment process. Cytotoxicity testing belongs to the group of endpoints for biological evaluation of medical devices and its whole process is defined in ISO 10993-5 “Biological evaluation of medical devices – Part 5: Tests for in vitro cytotoxicity”. In a short time, it provides an initial information about toxicity, which serves as a good indicator of general toxic properties and thus it can reduce the number of in vivo models required for subsequent toxicity analyzes. There are different approaches to cytotoxicity testing, either direct contact toxicity evaluation or elution methods. In our study, we focused on the latter approach, namely on optimizing the preparation of the material extracts in accordance with recommendations from ISO 10993-12 “Biological evaluation of medical devices – Part 12: Sample preparation and reference materials”. Based on the specific properties of tested materials, we selected volume of solvent used per surface area of test samples. Material samples were extracted in appropriate cell culture medium supplemented with serum. The materials were extracted at 37 °C for 24 hours with continuous circulation of sterile material immersed in the extraction medium in sealed tubes. In addition, we further extended the analyzes to dose ranging cytotoxicity evaluation to determine the level at which cytotoxicity no longer occurs.
Links
TH04020540, research and development projectName: Nová bioaktivní hemostatika a krytí ran na bázi kolagenu a celulózy
Investor: Technology Agency of the Czech Republic
PrintDisplayed: 27/8/2024 00:33